Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.70 |
| ▸ | THPO | P40225 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.70 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.70 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.70 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.70 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.70 |
| ▸ | ACHE | P22303 | 1/20 | 0.70 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.70 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.70 |
| ▸ | DRD3 | P35462 | 1/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2682374 | 0.99 | ALDH1A1 (0.68) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL1071414 | 0.88 | SMN1; SMN2 (0.68) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL1071994 | 0.87 | ALDH1A1 (0.52) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL4104422 | 0.86 | CYP3A4 (0.67) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL16085123 | 0.85 | HIF1A (0.78) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL23394728 | 0.85 | CYP3A4 (0.65) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL29038261 | 0.83 | SMN1; SMN2 (0.62) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| SCHEMBL30462575 | 0.83 | SMN1; SMN2 (0.62) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| Melphalan SCHEMBL4697634 | 0.83 | HIF1A (0.94) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA | |
| Sarcolysin SCHEMBL28338888 | 0.83 | HIF1A (0.94) | ALDH1A1CYP3A4SMN1; SMN2HIF1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023078464-A1 | EPSILON-POLY-L-LYSINE-BASED DRUG CONJUGATE, INTERMEDIATE THEREOF, AND APPLICATION THEREOF | 上海弼领生物技术有限公司 | 2023-05-11 | — | — | WO | disclosed |
| US-8921596-B2 | Process for the preparation of melphalan hydrochloride | Emcure Pharmaceuticals, Ltd. (IN) | 2014-12-30 | — | — | US | disclosed |
| WO-2014141057-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER | KANDULA MAHESH (IN) | 2014-09-18 | — | — | WO | disclosed |
| EP-2268827-B1 | PROCESS OF MAKING OPTICALLY PURE MELPHALAN | NAVINTA LLC (US) | 2013-10-09 | — | — | EP | disclosed |
| US-20120116117-A1 | PROCESS FOR THE PREPARATION OF MELPHALAN HYDROCHLORIDE | EMCURE PHARMACEUTICALS LTD. (IN) | 2012-05-10 | — | — | US | disclosed |
| EP-2268827-A1 | PROCESS OF MAKING OPTICALLY PURE MELPHALAN | Navinta, llc. (US) | 2011-01-05 | — | — | EP | disclosed |
| WO-2009117164-A1 | PROCESS OF MAKING OPTICALLY PURE MELPHALAN | NAVINTA LLC (US) | 2009-09-24 | — | — | WO | disclosed |